Patient Services

The David C. Koch Regional Cancer Therapy Center currently treats cancers with several forms of HIPEC:

Intraperitoneal Hyperthermic Chemotherapy is used to treat cancers of the abdomen and chest, including:

• Peritoneal Carcinomatosis
  • Appendiceal Primary
  • Colon Primary
  • Ovarian Primary (in rare cases)
• Adenomucinosis
• Primary Serous Adenocarcinoma of the Peritoneum
• Mesothelioma - peritoneal or pleural
• Pseudomyxoma Peritoneii
• Peritoneal Sarcomatosis

Regional Liver Perfusion is used to treat non-primary hepatic cancers, including:

• Colon cancer that has metastacized to the liver
• Liver metastasis from other primary cancers

Limb Perfusion is used to treat:

• Malignant melanoma of an extremity

These techniques have been well established from a technical perspective, and success against cancer has been demonstrated. Isolated liver perfusion has been associated with a 74-percent response rate and 27-month median survival in patients with unresectable colorectal metastases. A randomized trial has demonstrated a 10-month improvement in median survival in patients treated with intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis from colon cancer. Isolated limb perfusion is associated with a 78 to 100 percent overall response rate in patients with advanced melanoma.